Related references
Note: Only part of the references are listed.Treatment landscape of triple-negative breast cancer - expanded options, evolving needs
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
Golnaz Morad et al.
CELL (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
Eric P. Winer et al.
LANCET ONCOLOGY (2021)
Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Malignant Melanoma Receiving Immune Checkpoint Inhibitors-A Retrospective, Real-World Cohort Study
Maximilian Haist et al.
CANCERS (2021)
Roles of factor Xa beyond coagulation
Wolfram Ruf
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)
Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion
Yan Lan et al.
CANCER CELL (2021)
Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment Approach
Yacine Bareche et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer
Joan M. Romero et al.
CLINICAL CANCER RESEARCH (2020)
Role of Immunotherapy in Triple-Negative Breast Cancer
Tanya E. Keenan et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Down-regulation of tissue factor inhibits invasion and metastasis of non-small cell lung cancer
Qing Xia et al.
JOURNAL OF CANCER (2020)
Positive progress: current and evolving role of immune checkpoint inhibitors in metastatic triple-negative breast cancer
Christine E. Simmons et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers
Tina Gruosso et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Genomic correlates of response to immune checkpoint blockade
Tanya E. Keenan et al.
NATURE MEDICINE (2019)
Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1-Dependent Immune Evasion
Yi Yang et al.
CANCER RESEARCH (2019)
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
Leonie Voorwerk et al.
NATURE MEDICINE (2019)
Myeloid cell-synthesized coagulation factor X dampens antitumor immunity
Claudine Graf et al.
SCIENCE IMMUNOLOGY (2019)
Cold Tumors: A Therapeutic Challenge for Immunotherapy
Paola Bonaventura et al.
FRONTIERS IN IMMUNOLOGY (2019)
Current treatment landscape for patients with locally recurrent inoperable or metastatic triple-negative breast cancer: a systematic literature review
Claire H. Li et al.
BREAST CANCER RESEARCH (2019)
Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis
Steven P. Grover et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON
Zhiwei Hu et al.
CANCER IMMUNOLOGY RESEARCH (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Tumor-Derived Tissue Factor Aberrantly Activates Complement and Facilitates Lung Tumor Progression via Recruitment of Myeloid-Derived Suppressor Cells
Xiao Han et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Molecular alterations in triple-negative breast cancer-the road to new treatment strategies
Carsten Denkert et al.
LANCET (2017)
Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma
Xuesai Zhang et al.
ONCOTARGET (2017)
Surface Expression of TGFβ Docking Receptor GARP Promotes Oncogenesis and Immune Tolerance in Breast Cancer
Alessandra Metelli et al.
CANCER RESEARCH (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Tissue Factor: Old and New Links with Cancer Biology
Henri H. Versteeg
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2015)
VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice
Spela Ferjancic et al.
BLOOD (2013)
Tissue Factor as a Novel Target for Treatment of Breast Cancer
Marion Cole et al.
ONCOLOGIST (2013)
Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice
Ana M. Gil-Bernabe et al.
BLOOD (2012)
Role of Tissue Factor in Venous Thrombosis
David A. Manly et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 (2011)
Tissue Factor-Activated Coagulation Cascade in the Tumor Microenvironment Is Critical for Tumor Progression and an Effective Target for Therapy
Yuan Liu et al.
CANCER RESEARCH (2011)
Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development
Florence Schaffner et al.
BLOOD (2010)
Pattern of metastatic spread in triple-negative breast cancer
Rebecca Dent et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Role of Tissue Factor in Cancer
Raj S. Kasthuri et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice
Henri H. Versteeg et al.
CANCER RESEARCH (2008)
Inhibition of tissue factor signaling suppresses tumor growth
Henri H. Versteeg et al.
BLOOD (2008)
Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer
Alok A. Khorana et al.
CLINICAL CANCER RESEARCH (2007)
Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways
Yingmei Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Thrombin generation and the pathogenesis of cancer
Wolfram Ruf et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma
N Nitori et al.
CLINICAL CANCER RESEARCH (2005)
Share Paper
